Editas Medicine Inc at JPMorgan Biotech Fireside Investor Series Transcript
Welcome, and thank you for standing by. I would like to inform all participants that this conference call is being recorded and will be available to clients of JPMorgan. Parts of this conference call may also be reproduced in JPMorgan Research. If you have any objections, you may disconnect at this time. Press participants are not permitted on this call and should disconnect now.
Unless otherwise permitted by internal JPMorgan policy, members of JPMorgan investment and corporate banking are not permitted on this call and should disconnect now. Unless otherwise permitted by internal JPMorgan policy, members of JPMorgan investment and corporate banking are not permitted on this call and should disconnect now.
I would now like to turn the call over to Brian Cheng with JPMorgan. You may proceed.
Thanks, Anna. Good afternoon, everyone. Thanks for joining us on our biotech call series at JPMorgan. I'm Brian Cheng, one of the senior biotech analysts here at the firm. For those of you who are live on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |